Powered by 
Google Übersetzer
Google Übersetzer
22 May 2026
BSF Enterprise PLC
Posting of Circular and Notice of General Meeting
Further to the Company's announcement of 2 April 2026, BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a global pioneer in lab-grown tissues and sustainable biotechnology, announces that it has today posted a circular (the "Circular"), containing a notice of general meeting, to shareholders.
The general meeting will be held at the offices of Bowsprit Partners Limited, Birchin Court, 20 Birchin Lane, Bank, London, EC3V 9DU, United Kingdom at 11.00 a.m. on 8 June 2026 (the "General Meeting").
The Circular and Form of Proxy are available on the Company's website at www.bsfenterprise.com.
The Circular sets out details of the resolutions to be proposed at the General Meeting, including resolutions to renew and increase the directors' authorities to allot shares and to disapply statutory pre-emption rights. The proposed authorities are intended principally to facilitate the Company's existing share issuance obligations and other matters described in the Circular.
The expected timetable of principal events is set out below:
|
Event |
Time and Date |
|
Publication and posting of the Circular and Form of Proxy |
22 May 2026 |
|
Latest time and date for receipt of Forms of Proxy |
11.00 a.m. on 4 June 2026 |
|
Latest time and date for receipt of CREST proxy instructions |
11.00 a.m. on 4 June 2026 |
|
General Meeting |
11.00 a.m. on 8 June 2026 |
|
Announcement of results of the General Meeting |
8 June 2026 |
Notes
1. The above times and dates are indicative only and may be adjusted by the Company. Any changes will be announced through a Regulatory Information Service.
2. All references to time are to London time.
END
Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here:
https://bsfenterprise.com/link/yV08Zr
For further enquiries, please visit www.bsfenterprise.com or contact:
|
BSF Enterprise PLC Geoff Baker - Chairman Che Connon - CEO & Director
We encourage all investors to share questions on this announcement via our investor website. |
|
|
Bowsprit Partners John Treacy James Sheehan |
+44 (0)203 883 4430 |
|
Shard Capital (Broker) Damon Heath Isabella Pierre |
(0)20 4530 6926 (0)20 4530 6928 |
|
ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. |
|
Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
About BSF Enterprise PLC
BSF Enterprise PLC (LSE:BSFA; OTCQB: BSFAF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike.
